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Abstract
BACKGROUND: Enteropathogenic E. coli (EPEC) is a prominent cause of diarrhoea, and is
characterised in part by its carriage of a pathogenicity island: the locus for enterocyte effacement (LEE).
EPEC is divided into two subtypes according to the presence of bundle-forming pili (BFP), a fimbrial
adhesin that is a virulence determinant of typical EPEC (tEPEC), but is absent from atypical EPEC
(aEPEC). Because aEPEC lack BFP, their virulence has been questioned, as they may represent
LEE-positive Shiga toxin-producing E. coli (STEC) that have lost the toxin-encoding prophage, or
tEPEC that have lost the genes for BFP. To determine if aEPEC isolated from humans in Australia or
New Zealand fall into either of these categories, we undertook phylogenetic analysis of 75 aEPEC
strains, and compared them with reference strains of EPEC and STEC. We also used PCR and DNA
hybridisation to determine if aEPEC carry virulence determinants that could compensate for their lack of
BFP. RESULTS: The results showed that aEPEC are highly heterogeneous. Multilocus sequence typing
revealed that 61 of 75 aEPEC strains did not belong to known tEPEC or STEC clades, and of those that
did, none expressed an O:H serotype that is frequent in tEPEC or STEC strains associated with disease.
PCR for each of 18 known virulence-associated determinants of E. coli was positive in less than 15% of
strains, apart from NleB which was detected in 30%. Type I fimbriae were expressed by all aEPEC
strains, and 12 strains hybridised with DNA probes prepared from either bfpA or bfpB despite being
negative in the PCR for bfpA. CONCLUSION: Our findings indicate that clinical isolates of aEPEC
obtained from patients in Australia or New Zealand are not derived from tEPEC or STEC, and suggest
that functional equivalents of BFP and possibly type I fimbriae may contribute to the virulence of some
aEPEC strains.
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Abstract
Background: Enteropathogenic E. coli (EPEC) is a prominent cause of diarrhoea, and is
characterised in part by its carriage of a pathogenicity island: the locus for enterocyte effacement
(LEE). EPEC is divided into two subtypes according to the presence of bundle-forming pili (BFP), a
fimbrial adhesin that is a virulence determinant of typical EPEC (tEPEC), but is absent from atypical
EPEC (aEPEC). Because aEPEC lack BFP, their virulence has been questioned, as they may represent
LEE-positive Shiga toxin-producing E. coli (STEC) that have lost the toxin-encoding prophage, or
tEPEC that have lost the genes for BFP. To determine if aEPEC isolated from humans in Australia
or New Zealand fall into either of these categories, we undertook phylogenetic analysis of 75
aEPEC strains, and compared them with reference strains of EPEC and STEC. We also used PCR
and DNA hybridisation to determine if aEPEC carry virulence determinants that could compensate
for their lack of BFP.
Results: The results showed that aEPEC are highly heterogeneous. Multilocus sequence typing
revealed that 61 of 75 aEPEC strains did not belong to known tEPEC or STEC clades, and of those
that did, none expressed an O:H serotype that is frequent in tEPEC or STEC strains associated with
disease. PCR for each of 18 known virulence-associated determinants of E. coli was positive in less
than 15% of strains, apart from NleB which was detected in 30%. Type I fimbriae were expressed
by all aEPEC strains, and 12 strains hybridised with DNA probes prepared from either bfpA or bfpB
despite being negative in the PCR for bfpA.
Conclusion: Our findings indicate that clinical isolates of aEPEC obtained from patients in
Australia or New Zealand are not derived from tEPEC or STEC, and suggest that functional
equivalents of BFP and possibly type I fimbriae may contribute to the virulence of some aEPEC
strains.
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Strains of enteropathogenic E. coli (EPEC) are a well-rec-
ognised cause of diarrhoea, particularly in children in less
developed countries [1,2]. EPEC are characterised in part
by their ability to induce attaching-effacing (A/E) lesions
in the intestine [3-5]. These lesions are comprised of bac-
teria intimately attached to the intestinal mucosa at sites
of cytoskeletal rearrangements leading to characteristic
morphological changes, known as cupping and pedestal
formation, accompanied by the absence of microvilli. The
genes required for the production of these lesions are
located on a pathogenicity island known as the locus for
enterocyte effacement (LEE), which encodes (i) intimin,
an outer membrane protein product of the eae gene that
acts as an adhesin, (ii) a type III protein secretory system,
and (iii) several effector proteins secreted by the type III
system, including a translocated intimin receptor, Tir,
which, once bound to intimin, serves as an anchor for
host cytoskeletal proteins [6]. EPEC is divided into two
subtypes: typical and atypical. Typical EPEC (tEPEC)
strains carry a ca. 90-kb EPEC adherence factor plasmid
(pEAF) that encodes type IV-like bundle-forming pili
(BFP) [7]. The latter facilitate the adherence of bacteria to
the intestinal mucosa and to each other, allowing them to
form micro-colonies on epithelial cells in vitro and in vivo
[8,9]. Studies with adult volunteers have demonstrated
that intimin, pEAF and BFP are essential virulence deter-
minants of EPEC [10-12]. Interestingly, there is evidence
that a subset of EPEC strains, known as atypical EPEC
(aEPEC), which lack pEAF and BFP, are also pathogenic
[2].
aEPEC is defined as E. coli which possess LEE, but lack
pEAF/BFP and do not produce Shiga toxins [13]. Evidence
of the pathogenicity of aEPEC comes from case control
studies of paediatric diarrhoea in several countries
throughout the world, including Australia, Iran, Norway,
Peru, Poland, South Africa, the United Kingdom and the
USA (reviewed in [2,14]). In addition, at least three sepa-
rate studies have shown an association between infection
with aEPEC and persistent diarrhoea in children [14-16].
Notwithstanding these reports, the pathogenicity of
aEPEC remains controversial, chiefly because several stud-
ies have found aEPEC in patients with diarrhoea and con-
trol subjects at similar frequencies. These conflicting
observations prompt the question of whether aEPEC com-
prise a homogeneous group of pathogens with shared vir-
ulence determinants, such as adhesins analogous to BFP,
or whether they are heterogeneous, with one or more sub-
sets being more virulent than others. Although some clin-
ical isolates of A/E strains of E. coli which meet the
definition of aEPEC, appear to be Shiga-toxin producing
strains of E. coli (STEC) that have lost the Shiga toxin-
encoding bacteriophage(s) during passage through the
intestine [17], others may be tEPEC strains that have lost
pEAF [12]. Alternatively, aEPEC may represent a distinct
subset of human-specific strains of A/E E. coli or be
acquired from domestic animals, such as calves and rab-
bits, that are commonly infected with EPEC strains, which
lack pEAF [18,19]. In this study we characterised a large
number of clinical isolates of aEPEC from humans by
multi-locus sequence typing (MLST), PCR and/or DNA
hybridisation for E. coli virulence-associated determi-
nants, intimin type, HEp-2 adherence pattern and type 1
pilus production as a way of addressing these questions.
Results
MLST analysis
We have previously reported that aEPEC isolates obtained
during a water quality study were heterogeneous in terms
of serotype, intimin type and patterns of adherence to
HEp-2 cells [20]. This overall heterogeneity was con-
firmed by MLST analysis, which showed that 56 of the 79
aEPEC strains of human origin investigated in the study
belonged to one of 11 different clades and that 23 strains
could not allocated to a clade (Figure 1). As observed with
phylogenetic analyses of A/E strains of E. coli in general,
there was a tendency for each clade to contain strains with
the same intimin and flagellar type. Five of 11 clades
which contained aEPEC strains in this study were clades
that include either tEPEC or STEC strains, whereas six
clades were apparently distinct for aEPEC. These six clades
comprised one which contained three strains with
intimin-β and H7 (and O-antigens, O25 or O153); one
clade with seven strains with intimin-ν and H19 (all O-
nontypable [nt]); one clade with six strains with intimin-
θ and H21 (O119 and Ont); a clade with five strains with
intimin-ι and H8 or H- (O98, O107 or O177); one with
four strains with intimin-κ and H10 or H- (O49, O88, and
O153), and one with 13 strains with intimin-α and H6 or
H34 (O71, O125, O126, and Ont). The last-mentioned
clade was closely related to a tEPEC clade (EPEC-1), which
also comprises strains with intimin-α and flagellar anti-
gen, H6.
Of the strains that clustered with known clades of tEPEC
or EHEC, three (all intimin-γ and O55:H7) belonged to
the EHEC-1 clade, which also includes the pandemic, pro-
totypical O157:H7 EHEC clone. Five aEPEC isolates
grouped within the EPEC-2 clade which includes pEAF/
BFP-positive strains with intimin-β and H2. The aEPEC
serotypes in this clade included O15:Hnt, O114:H2,
O117:H2, O128:H2, and Ont:H2. This clade also con-
tained the prototypical aEPEC strain, E128012 [12], two
rabbit-specific EPEC (REPEC) strains, 84/110/1 and E22
(both of which carry intimin-β and are serotype
O103:H2), and a calf isolate, also O103:H2, but with
intimin-ε. Four aEPEC strains were assigned to the EPEC-
4 clade (intimin-β and H6). All of these strains were
intimin-β; two were O33:H6, and the others werePage 2 of 11
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Phylogenetic relationships of sequence types of 95 strains of attaching-effacing E. coliFigure 1
Phylogenetic relationships of sequence types of 95 strains of attaching-effacing E. coli. An unrooted phylogenetic 
tree was constructed by the neighbour-joining algorithm based on the Kimura two-parameter model of nucleotide substitu-
tion. Bootstrap values greater than 50% based on 500 replications are given at the internal nodes. Strain names highlighted in 
pink are reference strains of typical EPEC or STEC; those highlighted in pale blue and yellow were originally isolated from cat-
tle and rabbits, respectively, those highlighted in green were from children with persistent diarrhoea, and those highlighted in 
grey were from humans without diarrhoea. The right hand column indicates distinctive aEPEC clades in boldface type. The 
intimin and flagella type is shown for each clade. Abbreviations: nt, non-typable; int, intimin; ND, not determined.
O111:H2 (StokeW); O114:H2 (E128012); 
Ont:H2 (D5301, 13000) int-β
O127:H6 (E2348/69); O142:H6 (C771) int-α
O25:H7 (NT11); O153:H7 (R89, R104) int-β
O170/172:H49 (R227); O172/176:H9 (W1108) int-θ
O98:H- (06344) int-β
O161:H40 (W7) int-β
Ont:H19 (NT357, NT741, NT478, NT756, 
NT896, R278); Ont:H- (W1092) int-ν
O15:H- (83/39); O177:H11 (06409) int-β
O26:H- (E65/56); O111:H11 (06406); O111:H- (06403);
Ont:H- (F41, 06370) int-β
Ont:H21 (NT561) int-θ
O119:H21 (ESA14, ESA157); Ont:H6 (W1134-1); 
Ont:H21 (R420, W185) int θ
O103:H2 (E22, 84/110-1) int-β
O15:Hnt (W1040) int-β; O103:H2 (13931H) int-ε; 
O117:H2 (R215-1) int-β
O128:H2 (R404) int-β
O177:H- (NT286) int-ζ
Ont:H- (NT786) int-ι
O98:H8 (ESA212, R396); O107:H8 (W114); 
Ont:H8 (R176) int-ι
O45:H19 (NT731) int-γ
O153:H9 (NT564) int-θ
ND (R69) int-θ
O111:H25 (12997) int-θ
Ont:H40 (R182, W1585) int-θ
O49:H10 (13015, R281); O88:H- (R228-1) int-κ
O28:H- (11980) int-γ
O5/71:H31 (R394) int-θ
O55:H7 (NT611, W145, W1056) int-γ
O157:H7 (EDL933) int-γ
O2:H- (20439) int-λ
O33:H6 (R249-2, R436) int-β
O139:H14 (W154) int-β
Ont:H6 (W1082) int-β
O28:H45 (R446-2); Ont:H31 (R380) int-ζ
OR:H- (NT61, W85-2) int-θ
Ont:H5 (W143) int-ε
O128:H21 (R175) int-κ
O2:H45 (R261, 13001); O86:H34 (E990) int-κ
O123:H45 (NT526, 13026) int-ε
O124:H40 (W761) int-λ
O51:H49 (R219, W1068) int-α
O145:H34 (R249-1) int-ι
O157:H39 (NT251) int κ
Ont:H6 (R392, W1706) int-α
Ont:H34 (R41, R151-1, R446-1, W1120) int-α; Ont:Hnt (R218) int-α
O71:H6 (13020, R154) int-α; O126:H6 (W1118) int-α;
O125:H6 (13017, W902, W914) int-α
78
100
96
66
78
64
64
58
4554
100
80
100
99
96
100
100
100
100
100
55
73
96
86
94
64
56
68
97
50
61
92
66
100
0.001
aEPEC; int-β H7
aEPEC; int-ν H19
EHEC-2; int-β H11
aEPEC; int-θ H21
EPEC-2; int-β H2
aEPEC; int-ι H8
aEPEC; int-κ H10
EHEC-1; int-γ H7
EPEC-4; int-β H6
EPEC-3; int-κ H34
EPEC-1; int-α H6
Clade
aEPEC; int-α H6
O153:Hnt (12998) int-κ
BMC Microbiology 2009, 9:117 http://www.biomedcentral.com/1471-2180/9/117O139:H14 and Ont:H6. Two aEPEC strains, both O2:H4,
intimin-κ, belonged to the EPEC-3 clade, which also
included tEPEC strain O86:H34, intimin-κ. Overall, three
of 75 Australian and New Zealand isolates from humans
reported here belonged to EHEC clades, 11 fell within
EPEC clades, 38 belonged to clades distinct for aEPEC,
and 23 could not be classified.
Of the eight Australian calf isolates examined, three were
not assigned to a particular clade, and four belonged to
the EHEC-2 clade (intimin-β and H11), but were of differ-
ent serotypes from each other (O111:H-, O111:H11,
O177:H11 and Ont:H-). This clade also included arche-
typal aEPEC strains E65/56 (O26:H-) and F41 (Ont:H-),
which were isolated in Europe more than 50 years ago,
and a well-studied, REPEC strain, 83/39 (O15:H-), in
which Ral, a K88-like adhesin, was first identified [21].
None of the Australian or New Zealand strains of human
origin investigated in this study belonged to this clade,
suggesting that there was no major exchange of aEPEC
strains between the cattle and humans from whom these
bacteria were obtained. One calf isolate (O103:H2) was
assigned to the EPEC-2 clade, which also contained
REPEC strains E22 and 84/110-1 (also O103:H2), tEPEC
strain, Stoke W (O111:H2), and the prototypical aEPEC
strain, E128012 (O114:H2). No aEPEC strains carrying
intimin-β2, -ξ, -o, -ρ or -σ were identified in the entire col-
lection of 87 test and 8 reference strains reported here.
Frequency of adhesins and other virulence determinants of 
pathogenic E. coli in aEPEC strains
None of the 67 Australian aEPEC strains of human origin
investigated in this study was positive in the PCR for genes
encoding the following adhesins of pathogenic E. coli:
BFP, Lda, Pap, Saa, Afa, Sfa/Foc, K88, K99, Af/R2 or RalG
(Table 1). On the other hand, all strains were positive in
the PCR for FimH of Type 1 pili. Moreover, all isolates
exhibited mannose-sensitive haemagglutination, indicat-
ing that they produced functional Type 1 pili.
One strain, NT731 (O45:H19, intimin-γ) was the only
one of the 67 aEPEC isolates investigated that was positive
in the PCR for Afa, a virulence determinant of uropatho-
genic E. coli that also serves as an adhesin in some EPEC
strains [22,23].
Two strains, R89 and R104, which belonged to a distinct
aEPEC clade, characterised by intimin-β and H7 flagella,
were positive in the PCR for AF/R1, a fimbrial adhesin and
essential virulence determinant of the prototypical REPEC
strain, RDEC-1 [24]. One strain, R219 (O51:H49,
intimin-α), was the only one that tested positive for AggA,
the pilin subunit of enteroaggregative E. coli [25]. Three
strains, NT286, NT731, and NT786, were positive in the
PCR for Iha, an adherence-conferring protein that is
highly prevalent in STEC [26]. The Iha-positive aEPEC
strains identified here were unrelated to each other and to
STEC in terms of MLST type, intimin type and serotype
(Table 1, Figure 1).
The PCR for long polar fimbriae (Lpf) was positive in 13
(19%) of 67 strains, all of which were from patients with
diarrhoea. Lpf-positive strains occurred within the EPEC-
2 clade (3 strains), the aEPEC clade with intimin-ν and
H19 (7 strains), and the aEPEC clade with intimin-β and
H7 (3 strains). Overall, seven of the LPF-positive isolates
carried intimin-ν, and six had intimin-β.
We and others have previously reported that certain deter-
minants of EPEC, which are not encoded by LEE or the
EAF plasmid, such as Efa1, NleB and the cytolethal dis-
tending toxin (Cdt) are associated with virulence in
attaching-effacing E. coli [15,27]. NleB was detected in 20
(30%) of the 67 strains tested, whereas Efa1 was detected
in 8 strains (12%), all of which were also positive for
NleB. NleB-positive strains were distributed amongst the
following clades: EHEC-1 (3 strains), EPEC-2 (2 strains),
aEPEC-1 (intimin-β, H7; 3 strains), aEPEC-3 (intimin-θ,
H21 [or H6]; 6 strains). Six NleB-positive isolates could
not be assigned to a clade, although all carried intimin-θ
(Table 1). The Efa1-positive strains occurred within the
EHEC-1 and EPEC-2 clades, as well as within the aEPEC-
1 clade that was characterised by strains with intimin-β
and H7. Seven (10%) strains were positive in the PCR for
Cdt. Three of these strains belonged to the aEPEC-6 clade
(intimin-α and H34), one belonged to EPEC-2 (intimin-
β, H2), and three were unassigned (Table 1).
DNA hybridization
To determine if aEPEC carry DNA sequences related to
those that code for the production of BFP, but were not
amplified by the PCR for BfpA, we investigated the aEPEC
strains by DNA hybridisation using probes derived from
the bfpA and bfpB genes of EPEC strain E2348/69. Unex-
pectedly, six isolates (ESA212, R176, R182, R228-1, R281,
and W114) hybridised with the BfpA probe at high strin-
gency. Three of these strains belonged to the aEPEC clade
with intimin-ι and H8, but they belonged to different O-
serogroups. The other three probe-positive strains also dif-
fered from each other. Six strains hybridised with the BfpB
probe. Four of these were positive for intimin-α, three car-
ried H34, two carried H6, but all were of different sero-
types. No strain hybridised with both Bfp probes.
Some aEPEC strains from humans and animals express
adhesins that are homologous to the K88 fimbriae of
enterotoxigenic E. coli [21,28]. To determine if the aEPEC
strains in our collection carried similar sequences, wePage 4 of 11
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Table 1: Characteristics of atypical EPEC strains that were positive in one or more PCR or DNA hybridization assays for virulence-
associated determinants of E. colia
Result of assay using:
PCR for Probe for
Strain Serotype Clade Intimin Afa Afr/I AggA Cdt Efa1 Iha LpfD NleB BfpA BfpB HEp-2 adhesionb
ESA14 O119:H21 aEPEC3 θ - - - - - - - + - - NA
ESA157 O119:H21 aEPEC3 θ - - - - - - - + - - NA
ESA212 O98:H8 aEPEC4 ι - - - - - - - - + - NA
NT11 O25:H7 aEPEC1 β - - - - + - + + - - IA
NT286 O177:H- ζ - - - - - + - - - - NA
NT357 Ont:H19 aEPEC2 ν - - - - - - + - - - IA
NT478 Ont:H19 aEPEC2 ν - - - - - - + - - - NA
NT526 O123:H45 ε - - - + - - - - - - IA
NT561 Ont:H21 aEPEC3 θ - - - - - - - + - - AA
NT611 O55:H7 EHEC1 γ - - - - + - - + - - AA
NT731 O45:H19 γ + - - - - + - - - - NA
NT741 Ont:H19 aEPEC2 ν - - - - - - + - - - IA
NT756 Ont:H19 aEPEC2 ν - - - - - - + - - - IA
NT786 OR:H- aEPEC4 ι - - - - - + - - - - AA
NT896 Ont:H19 aEPEC2 ν - - - - - - + - - - IA
R104 O153:H7 aEPEC1 β - + - - + - + + - - AA
R151-1 Ont:H34 aEPEC6 α - - - + - - - - - + AA
R176 Ont:H8 aEPEC4 ι - - - - - - - - + - NA
R182 OR:H40 θ - - - - - - - + + - IA
R215-1 O117:H2 EPEC2 β - - - - + - + + - - IA
R218 Ont:R aEPEC6 α - - - + - - - - - + AA
R219 O51:H49 α - - + - - - - - - - AA
R227 O170/172:H49 θ - - - - - - - + - - IA
R228-1 O88:H- aEPEC5 κ - - - - - - - - + - NA
R249-1 O145:H34 ι - - - - - - - - - + AA
R278 Ont:H19 aEPEC2 ν - - - - - - + - - - IA
R281 O49:H10 aEPEC5 κ - - - - - - - - + - NA
R380 Ont:H31 ζ - - - + - - - - - - AA
R392 Ont:H6 aEPEC6 α - - - - - - - - - + AA
R394 O5/71:H31 θ - - - - - - - + - - IA
R404 O128:H2 EPEC2 β - - - + - - + - - + LA-L
R420 Ont:H21 aEPEC3 θ - - - - - - - + - - IA
R446-1 Ont:H34 aEPEC6 α - - - + - - - - - + AA
R446-2 O28:H45 ζ - - - + - - - - - - AA
R69 NT θ - - - - - - - + - - IA
R89 O153:H7 aEPEC1 β - + - - + - + + - - IA
W1040 O15:Hnt EPEC2 β - - - - + - + + - - LA-L
W1056 O55:H7 EHEC1 γ - - - - + - - + - - IA
W1092 OR:H- aEPEC2 ν - - - - - - + - - - IA
W1108 O176/172:H49 θ - - - - - - - + - - IA
W1134-1 Ont:H6 aEPEC3 θ - - - - - - - + - - NA
W114 O107:H8 aEPEC4 ι - - - - - - - - + - NA
W145 O55:H7 EHEC1 γ - - - - + - - + - - AA
W1585 Ont:H40 θ - - - - - - - + - - NA
W185 Ont:H21 aEPEC3 θ - - - - - - - - - - IA
a No strain was positive in the PCR for BFP, Lda, Pap, Saa, Afa, Sfa/Foc, K88, K99, Af/R2 or RalG, and no strain hybridised with a probe for K88. All 
strains were positive in the PCR for FimH. b Adherence pattern after 3 hours' incubation with HEp-2 cells: AA, aggregative adherence; IA, 
indeterminate pattern; LA-L, localised-like adherence; NA, non-adherent.
BMC Microbiology 2009, 9:117 http://www.biomedcentral.com/1471-2180/9/117probed these strains for the fae gene of K88, but none of
the aEPEC hybridised with this probe, even when tested at
low stringency.
Adherence to HEp-2 cells
After incubation for three hours with HEp-2 cells, 54
(81%) of 67 aEPEC strains were adherent: 24 strains
adhered in an aggregative pattern, and two in the pattern
termed "localised-like adherence", because it resembles
BFP-mediated localised adherence, but the bacteria are
more loosely associated with each other than BFP-bearing
strains. Twenty-eight strains showed an indeterminate
pattern of adherence described previously [20], in which
bacteria adhere in a mixed pattern of diffuse and local-
ised-like adherence. Thirteen strains did not adhere to
HEp-2 cells after 3 hours. Extending the contact period of
the bacteria with the HEp-2 cells from 3 to 6 hours
allowed some strains that had not adhered after 3 hours
to adhere in an indeterminate pattern, but the pattern of
strains that were adherent after 3 hours did not change.
Five of the six strains that hybridised with the BfpA probe
were non-adherent after three hours, whereas five of the
six BfpB-positive strains showed aggregative adherence
and one showed localised-like adherence. Adherence to
HEp-2 cells was not associated with a positive PCR for
either Lpf or Efa.
Association of specific virulence determinants with clinical 
presentation
The 67 aEPEC strains we investigated by PCR, DNA
hybridisation and for adherence to HEp-2 cells originated
from individuals with different clinical presentations
(Table 2). Fifty-seven isolates were obtained from patients
with diarrhoea, and ten were from asymptomatic individ-
uals. Eleven isolates were from children with persistent
diarrhoea (i.e., diarrhoea lasting more than 14 days), and
12 were from children with diarrhoea less than 14 days in
duration. Thirty-four strains were from patients in whom
the duration of diarrhoea was not known. To determine if
any of the putative accessory virulence determinants of
aEPEC that were sought in this study were associated with
a particular clinical presentation, we compared the fre-
quency of these determinants in isolates from patients
with and without diarrhoea, and those known to have
acute or persistent diarrhoea. The results showed that the
frequency of the factors investigated did not differ signifi-
cantly between the groups under comparison (P > 0.1,
Fisher's exact test, two-tailed).
Discussion
The classification of diarrhoeagenic strains of E. coli into
pathotypes has led to considerable improvement in our
understanding of the epidemiology, pathogenesis and
clinical presentation of infections with these bacteria, and
has spawned novel strategies to diagnose and prevent
these infections [29,30]. Each pathotype of diarrhoea-
genic E. coli carries a distinctive suite of virulence determi-
nants, almost all of which show evidence of having been
acquired on mobile genetic elements, such as plasmids,
transposons, bacteriophages and pathogenicity islands.
Interestingly, apart from their shared virulence determi-
nants, strains of each pathotype often differ from each
other in terms of serotype, biotype, phage type, and even
with regard to the nature of the specific virulence determi-
nants they carry, e.g., Shiga toxin-1 or Shiga toxin-2 in
EHEC, and heat-labile or heat-stable enterotoxin in enter-
otoxigenic E. coli [30,31].
It was not surprising, therefore, that the clinical isolates of
aEPEC we examined in this study were heterogeneous in
every way we investigated them, including by using MLST
to examine their phylogenetic relatedness. This analysis
confirmed that some strains are closely related to tEPEC,
while others are more like EHEC [32]. Indeed, one of the
aims of this study was to determine if aEPEC obtained
from patients with diarrhoea are derived from tEPEC that
have lost pEAF [12], or LEE-positive STEC strains that
have been cured of the Stx-encoding bacteriophage [17].
Phylogenetic analysis revealed that 3 aEPEC strains
obtained from 75 humans in Australia or New Zealand
belonged to EHEC clades, and 11 belonged to clades that
contain tEPEC. None of these 14 isolates belonged to
serotypes of highly virulent or epidemic EHEC or EPEC
and none carried the gene for EHEC-haemolysin
[14,20,33], suggesting that they did not recently arise
Table 2: Frequency of putative virulence-associated determinants of atypical EPEC strains in study subjects with different clinical 
presentations.
No. of strains positive for:a
Clinical presentation BfpA BfpB Cdt Efa1 LpfO113 NleB1
All diarrhoea (n = 57) 5 6 7 7 13 18
No diarrhoea (n = 10) 1 0 0 1 0 2
Acute diarrhoea (n = 12) 1 4 4 2 3 3
Persistent diarrhoea (n = 11) 2 0 1 0 1 4
a Only determinants that were present in more than three isolates overall were included in this analysis.Page 6 of 11
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ing that three aEPEC strains, which were clustered
together with EHEC O157:H7, were serotype O55:H7,
given the evidence that the latter appears to be the progen-
itor of EHEC O157:H7 [34].
Most of the strains we investigated (61 of 75) either
belonged to distinctive aEPEC clades or could not be clas-
sified, indicating further that they did not arise from
EHEC or tEPEC. Even those strains which clustered with
EPEC or EHEC generally were of serotypes that are not
common amongst tEPEC or STEC strains that are associ-
ated with infection of humans. Our finding that each bac-
terial isolate within each distinctive aEPEC clade generally
carried the same intimin type mirrors observations made
with tEPEC [35] and provides further evidence that E. coli
acquired the LEE pathogenicity island on a number of sep-
arate occasions.
aEPEC in different clades did not differ from one another
in terms of their association with acute or persistent diar-
rhoea. This conclusion is in keeping with our somewhat
unexpected finding that REPEC strains E22 and 83/39,
which carry closely related virulence determinants, and
are proven pathogens of infant rabbits in which they cause
a similar illness, clustered with EPEC and EHEC, respec-
tively.
Our search for virulence determinants in clinical isolates
of aEPEC revealed that a minority of strains carried homo-
logues of DNA sequences that encode known adhesins or
other virulence-associated determinants of pathogenic E.
coli. Overall, six strains each hybridised with DNA probes
for BfpA and BfpB, respectively, and PCR analysis gave
positive results for Lpf (13 strains), Iha (3 strains), AF/R1
(2 strains), Afa (1 strain), or AggA (1 strain). To our
knowledge, this is the first time that AF/R1 has been iden-
tified in any E. coli other than the prototypical REPEC
strain, RDEC-1 [36], but we have not determined if this
gene or any of the other putative virulence genes in the
probe- or PCR-positive aEPEC strains we investigated is
expressed by the strain that carries it. Moreover, no strain
was positive in the PCR for ldaH, which is the only known
specific adhesin of aEPEC identified so far [28].
In this study we were unable to confirm previous reports
that nleB or efa1, which are key components of a genomic
island of EPEC and virulent STEC [37], are markers of
symptomatic infection with aEPEC [38], largely because
these determinants were present in so few strains (present
in only 20 and 8 of 67 strains, respectively). We also did
not find any association between the presence of any
genes for particular virulence determinants and the clini-
cal presentation of patients in terms of the presence or
duration of diarrhoea, but the small number of probe- or
PCR-positive strains made the finding of statistically sig-
nificant associations unlikely.
All of the aEPEC strains we investigated in this study
expressed functional Type I pili. Although these pili are
widespread amongst all varieties of E. coli, including non-
pathogens, evidence is accumulating that these pili, which
are well established virulence determinants of uropatho-
genic and systemically invasive E. coli [39,40], may also
contribute to the virulence of EPEC and enteroaggregative
E. coli, particularly with respect to biofilm formation
[41,42]. Type I pili are also an essential virulence determi-
nant of adherent-invasive E. coli [43]. In addition, overex-
pression of Type I pili by a BFP-mutant of tEPEC was able
to compensate for the absence of BFP and allowed bacte-
ria to adhere to cultured epithelial cells in vitro [44].
Whether Type I pili contribute to the virulence of aEPEC,
however, remains to be determined.
Conclusion
Our findings show that aEPEC are highly heterogeneous
in terms of serotype, intimin type, multilocus sequence
type, pattern of adherence to HEp-2 cells, and their car-
riage of known virulence genes (apart from those encoded
by the LEE). Although we did not identify a common type
of adhesive fimbria in aEPEC that is functionally equiva-
lent to BFP, we cannot rule out that one exists. Indeed, the
fact that all tEPEC strains express BFP despite their phylo-
genetic heterogeneity supports the case for continued
efforts to identify specific adhesins of aEPEC.
Methods
Bacteria
For the purposes of this study, aEPEC were defined as
strains of E. coli that were positive by PCR for the eae gene,
but negative by PCR for the genes for BfpA and Shiga tox-
ins 1 and 2, using the PCR primers and conditions
described previously [14]. Sixty-seven of the aEPEC strains
investigated in this study were isolated in our laboratory
during the course of four separate studies: a Melbourne
water-quality study (21 strains with a prefix of W [20], a
study examining the clinical features of children infected
with aEPEC at the Royal Children's Hospital, Melbourne,
Australia (28 strains with a prefix of R [14]), a study of the
prevalence of STEC in Melbourne (3 strains, prefixed
ESA), and a study of acute diarrhoea in children in the
Northern Territory, Australia (15 strains, prefixed NT
[33]). The remaining clinical aEPEC isolates were
E128012, from a case of sporadic infant diarrhoea in
Bangladesh [12], F41 (Denmark [45]), E65/56 and
D5301 (England [46-48]), all of which are archetypal
aEPEC strains [49]. We also tested 8 clinical aEPEC strains
from New Zealand (kindly supplied by Jenny Bennett,Page 7 of 11
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isolated from symptomatic cattle in Australia [18] (kindly
supplied by Dr Steven Djordjevic, Elizabeth Macarthur
Agricultural Institute, Camden, NSW, Australia).
Reference strains of E. coli included in the phylogenetic
analysis of the aEPEC strains were: tEPEC (eae+ bfpA+)
strains, E2348/69, E990, Stoke W and C771 [12,49];
REPEC strains, E22 [50], 83/39, 84/110-1 [51], and an
STEC O157:H7 strain, EDL933, which is LEE-positive and
classified as enterohemorrhagic E. coli (EHEC) [52]. E. coli
strains used as controls for PCR included enteroaggrega-
tive E. coli strain 17-2 [53]; STEC strains, EH41 [54], and
EH52 (this study); enterotoxigenic E. coli strain K88 and
E. coli K12-K99+ (courtesy of Professor Peter Reeves, Uni-
versity of Sydney, Sydney, NSW, Australia); REPEC strains,
B10 [55], 83/39 and RDEC-1 [56], and uropathogenic E.
coli strain J96 [57]. Adherent-invasive E. coli strain LF82,
which was isolated from a chronic ileal lesion of a patient
with Crohn's disease, and 52D11 (an isogenic fimA
mutant of LF82) [43] were kindly supplied by Dr Arlette
Darfeuille-Michaud, Université d'Auvergne, Clermont-
Ferrand, France, and used as controls to test for mannose-
sensitive haemagglutination. Unless otherwise specified,
bacteria were routinely subcultured on horse blood agar
or Luria-Bertani agar (BD Difco, Franklin Lakes, NJ) at
37°C.
Preparation of DNA
Genomic DNA was isolated from E. coli using hexadecylt-
rimethylammonium bromide (CTAB) as described in
Ausubel et al. [58], and was used as the template for all
experiments requiring DNA.
Multi-locus sequence typing (MLST)
Eighty-three test strains isolated from humans or cattle in
Australia and New Zealand, together with four archetypal
aEPEC and eight A/E E. coli control strains were subjected
to MLST analysis using the methods described on the
EcMLST website http://www.shigatox.net/mlst. Briefly,
seven housekeeping genes (aspC, clpX, fadD, icdA, lysP,
mdh and uidA) were amplified with AmpliTaq Gold in 50
μl reaction volumes. PCR products (5 μl) were electro-
phoresed on 1% agarose gels to check the size and yield.
The remaining 45 μl was purified using the QIAquick PCR
Purification Kit (Qiagen, Valencia, CA) and eluted in 20 μl
elution buffer. Both strands of each gene were sequenced
using ABI PRISM BigDye Terminator (Applied Biosys-
tems, Foster City, CA) according to the manufacturer's
instructions. Sequences were checked and cropped to the
required length using Sequencher 4.0 (Gene Codes, Ann
Arbor, MI). Sequences were concatenated for phyloge-
netic analyses, and aligned with the ClustalW algorithm
using the MegAlign module of the Lasergene software
(DNASTAR Inc., Madison, WI). Neighbour-joining trees
were constructed using the Kimura two-parameter model
of nucleotide substitution with the MEGA3 software
(Center for Evolutionary Functional Genomics, Tempe,
AZ) [59]. The inferred phylogenies were each tested with
500 bootstrap replications.
Accession numbers
The sequences of the aspC, clpX, fadD, icdA, lysP, mdh and
uidA genes used for the MLST analysis have been depos-
ited in the GenBank data base under accession numbers
GQ130379 to GQ131022.
Intimin typing
The eae gene was subtyped by using the restriction frag-
ment length polymorphism assay described by Ramach-
andran et al. [60]. This method permits detection of the
following intimin types: α (alpha), β (beta), β2, γ
(gamma), ε (epsilon), ζ (zeta), θ (theta), ι (iota), κ
(kappa), λ (lambda), ν (nu), ξ (xi), o (omicron), ρ (rho),
and σ (sigma).
Detection of genes for adhesins and other virulence factors 
by using PCR
PCR amplifications were performed in a GeneAmp PCR
System 9700 thermal cycler (Applied Biosystems) or an
iCycler (Bio-Rad Laboratories, Hercules, CA) with Ampli-
Taq Gold polymerase (Applied Biosystems) in a reaction
volume of 20 μl. The genes, primers, amplicon size and
PCR conditions used for these studies are listed in the
additional file (see Additional file 1). The test strains for
these analyses, and those described below, were the 67
aEPEC strains obtained from humans in Australia. The
following E. coli strains were used as positive controls:
E2348/69 (bfpA), 83/39 (efa1, ralG), EDL933 (iha, nleB1),
EH41 (saa, lpfDO113); K88 (fae operon), K12-K99+ (fan
operon), 17-2 (aggA); J96 (fimH, papA, sfa/focDE, focG),
EH52 (afaC), RDEC-1 (afr1), B10 (afr2), and E990 (cdt).
PCR products were electrophoresed on 1–1.5% Tris-ace-
tate-EDTA agarose gels and stained with ethidium bro-
mide before visualisation on a UV transilluminator.
DNA Hybridisation
Genomic DNA was spotted onto Magna Nylon Transfer
Membranes (GE Osmonics, Trevose, PA) and denatured
and neutralised according to the "DIG System User's
Guide for Filter Hybridisation" (Roche, Mannheim, Ger-
many). Transferred DNA was UV-crosslinked using a
Spectrolinker XL-1000 UV crosslinker (Spectronics Corp.,
Westbury, NY). Digoxigenin-labelled DNA probes were
prepared by PCR (Roche) using primers to detect bfpA
(Table 1); primers MP-bfpB-F (GATAAAACTGATACT-
GGGCAGC) and MP-bfpB-R (AGTGACTGTTCGGGAAG-
CAC) to detect bfpB [61]; and primers faeEF
(ATGCGCCGGGTGATATCA) and faeER (TTATTTCT-
GCTCTGCGGT) to detect faeE. EPEC E2348/69 was usedPage 8 of 11
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genic E. coli strain K88 was used as template for the faeE
probe. These strains were also included as positive con-
trols on the appropriate membranes. Before use, probes
were sequenced using ABI PRISM Big Dye Terminator as
described above. Sequencing reactions were purified
using MgSO4 and submitted to the Australian Genome
Research Facility (Parkville, Vic, Australia). Hybridisation
was performed at low stringency (hybridisation at 50°C
followed by washing in 2× SSC at room temperature),
medium stringency (hybridisation at 59°C, washing in
0.1× SSC at 59°C), and high stringency (hybridisation at
68°C, washing in 0.1× SSC at 68°C), and detected by
using chemiluminescence as recommended by the manu-
facturer. Bacteria were considered probe-positive if the
intensity of the spot was similar to that of the positive con-
trol.
Bacterial adherence to HEp-2 cells
The Center for Vaccine Development method was used to
determine the pattern of bacterial adherence to HEp-2 epi-
thelial cells [62]. The criteria used to assign bacterial
adherence to a particular pattern have been described pre-
viously [20].
Type I pili production
The expression of Type I pili was determined by investigat-
ing bacteria for mannose-sensitive haemagglutination of
guinea pig erythrocytes. For these assays, bacteria were
grown in Brain Heart Infusion broth (Oxoid Ltd., Basing-
stoke, England) or Antibiotic Medium No. 3 (Penassay
broth, PAB; Oxoid Ltd.) at 37°C without shaking, and
tested for haemagglutination using the method described
by Iida et al. [63]. E. coli strains, LF82 and 52D11, were
used as positive and negative controls, respectively.
Strains that were haemagglutination-negative were
retested after passage through Brain Heart Infusion broth
to enhance the expression of Type I pili.
Abbreviations used
A/E: attacing-effacing; aEPEC: atypical EPEC; BFP: bundle-
forming pili; BHIB: brain heart infusion broth; Cdt: cyto-
lethal distending toxin; EHEC: enterohaemorrhagic
Escherichia coli; EPEC: enteropathogenic E. coli; LEE: locus
for enterocyte effacement; Lpf: long polar fimbriae; MLST:
multi-locus sequence typing; pEAF: EPEC adherence fac-
tor plasmid; REPEC: rabbit-specific EPEC; STEC: Shiga
toxin-producing E. coli; tEPEC: typical EPEC.
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